Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world.
A pioneer in the plasma industry, Grifols develops plasma-derived medicines and other innovative biopharmaceutical solutions that enable millions of patients with chronic and rare conditions to lead more productive lives.
As a recognized leader in transfusion medicine, we offer a comprehensive portfolio of solutions designed to enhance safety from donation to transfusion, in addition to clinical diagnostic technologies. We provide high-quality biological supplies for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. In addition, the company supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care.
Grifols, with over 27,000 employees in more than 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry.
Grifols International, S.A.
Avinguda de la Generalitat, 152
Parc empresarial Can Sant Joan
08174 Sant Cugat del Vallès, Barcelona
Tel. +34 935712200
Fax +34 938008000
Notification of adverse reactions
To report an adverse drug reaction click here